Home > Drug Search >
  • company_query: BioDem
  •   > 
Drug Filter
Category:
chemistry (18) biology (8)
Status:
Approved (2) Phase Ⅲ (5) Phase Ⅱ (10) Phase Ⅰ (7) IND Filing (2)
Clinical Stage:
Pending (4) Active (15) Discontinued (5)
Bio-Type:
Gene therapy (3) Vaccine (1) Other recombinant protein (1) Whole antibody (1)
Indication:
Acute coronary syndrome (ACS) (2) Acute otitis externa (AOE) (1) Basal cell carcinoma (BCC) (1) Brain ischemia (1) Cancer chemotherapy (1) Thrombotic microangiopathy (1) Delayed graft function (1) Metachromatic leukodystrophy (1) Wiskott-Aldrich syndrome (1) Diabetic macular edema (1) Dry age related macular degeneration (AMD) (1) Dyslipidemia (1) Heart failure (1) Hepatocellular carcinoma (HCC) (2) Hypertension (1) Idiopathic pulmonary fibrosis (IPF) (1) Non small cell lung cancer (NSCLC) (2) Haemolytic uraemic syndrome (1) Non-alcoholic fatty liver disease (NAFLD) (1) Obesity (1) Ovarian cancer (1) Pancreatic cancer (2) Postherpetic neuralgia (PHN) (1) Rheumatoid arthritis (RA) (1) Small cell lung cancer (SCLC) (1) Solid tumours (1) Thyroid cancer (1) Colorectal cancer (1) Nosocomial infections (1) Colon cancer (1) Age-related macular degeneration (AMD) (1) Pain (1) Diabetes (1) Sickle cell disease (1) Renal carcinoma (1) Autoimmune diseases (2) Adenosine deaminase deficiency (1) Glioblastoma (1) Plaque psoriasis (1) Thrombosis (1) Liver cancer (1) Thelassemia (1) Hypoxemia (1) Acquired thrombotic thrombocytopenic purpura (1) Inflammation (1)
Country:
Aprv. Year:
2014 (1) 2016 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top